Funding Rounds
Neurosterix

Neurosterix Series A (2024, $63M)

Neurosterix

Advanced allosteric modulator therapeutics developer for neurological disorders.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $63.00M

Raised Date: 2024-03-01